These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 17378926

  • 1. A retrospective nationwide case study on the use of a new antifungal agent: patients treated with caspofungin during 2001-2004 in Finland.
    Anttila VJ, Salonen J, Ylipalosaari P, Koivula I, Riikonen P, Nikoskelainen J.
    Clin Microbiol Infect; 2007 Jun; 13(6):606-12. PubMed ID: 17378926
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Efficacy of caspofungin against invasive Candida or invasive Aspergillus infections in neutropenic patients.
    Betts R, Glasmacher A, Maertens J, Maschmeyer G, Vazquez JA, Teppler H, Taylor A, Lupinacci R, Sable C, Kartsonis N.
    Cancer; 2006 Jan 15; 106(2):466-73. PubMed ID: 16353208
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Refractory Aspergillus pneumonia in patients with acute leukemia: successful therapy with combination caspofungin and liposomal amphotericin.
    Aliff TB, Maslak PG, Jurcic JG, Heaney ML, Cathcart KN, Sepkowitz KA, Weiss MA.
    Cancer; 2003 Feb 15; 97(4):1025-32. PubMed ID: 12569602
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. High rate of breakthrough invasive aspergillosis among patients receiving caspofungin for persistent fever and neutropenia.
    Lafaurie M, Lapalu J, Raffoux E, Breton B, Lacroix C, Socié G, Porcher R, Ribaud P, Touratier S, Molina JM.
    Clin Microbiol Infect; 2010 Aug 15; 16(8):1191-6. PubMed ID: 19735276
    [Abstract] [Full Text] [Related]

  • 14. Caspofungin for the treatment of candidaemia in patients with haematological malignancies.
    Pagano L, Fianchi L, Fanci R, Candoni A, Caira M, Posteraro B, Morselli M, Valentini CG, Farina G, Mitra ME, Offidani M, Sanguinetti M, Tosti ME, Nosari A, Leone G, Viale P.
    Clin Microbiol Infect; 2010 Mar 15; 16(3):298-301. PubMed ID: 19549221
    [Abstract] [Full Text] [Related]

  • 15. Salvage therapy with caspofungin for invasive aspergillosis: results from the caspofungin compassionate use study.
    Kartsonis NA, Saah AJ, Joy Lipka C, Taylor AF, Sable CA.
    J Infect; 2005 Apr 15; 50(3):196-205. PubMed ID: 15780413
    [Abstract] [Full Text] [Related]

  • 16. Invasive candidiasis treated in the intensive care unit: observations from a randomized clinical trial.
    DiNubile MJ, Lupinacci RJ, Strohmaier KM, Sable CA, Kartsonis NA.
    J Crit Care; 2007 Sep 15; 22(3):237-44. PubMed ID: 17869975
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Caspofungin for post solid organ transplant invasive fungal disease: results of a retrospective observational study.
    Winkler M, Pratschke J, Schulz U, Zheng S, Zhang M, Li W, Lu M, Sgarabotto D, Sganga G, Kaskel P, Chandwani S, Ma L, Petrovic J, Shivaprakash M.
    Transpl Infect Dis; 2010 Jun 15; 12(3):230-7. PubMed ID: 20070619
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.